BUSHLAND PHARMACEUTICALS: A subsidiary intends to invest RMB 222,000 to establish a joint-stock company.

Step Pharmaceutical announced that its holding subsidiary Zhejiang Huapai intends to jointly invest in the establishment of Nanjing Keyi Nuo Biotechnology Co., Ltd. with Hefei Keyinuo, Jiangsu Provincial Research Institute and Hefei Kesaixi. The registered capital is 2 million yuan, and Zhejiang Huapai holds a 11.11% stake, with a subscribed registered capital of 222,000 yuan.